Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Corneal Cross-Linking Treatment of Keratoconus Publisher



Farjadnia M1 ; Naderan M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cornea, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Tehran, Iran

Source: Oman Journal of Ophthalmology Published:2015


Abstract

Keratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several studies document Crosslink defect between collagen fibrils in the pathogenesis of keratoconus. Collagen cross link is a relatively new approach that with the application of the riboflavin and ultraviolet A, new covalent bands reform. Subjective and objective results following this method seem to be promising. Endothelial damage besides other deep structural injury, which is the major concern of this technique have not yet been reported, when applying the standard method.
Other Related Docs
11. Characteristics and Associations of Keratoconus Patients, Contact Lens and Anterior Eye (2015)
16. Myoring Implantation in Keratoconic Patients: 3 Years Follow-Up Data, Journal of Ophthalmic and Vision Research (2016)
22. Accelerated Corneal Collagen Cross-Linking in Pediatric Keratoconus, Journal of Current Ophthalmology (2021)